Microneedle Mediated Vaccine Delivery: A Comprehensive Review


  • Anureet Arora Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India
  • Manju Nagpal Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
  • Geeta Aggarwal Delhi Pharmaceutical Sciences and Research University, Sector 3, Pushpvihar, New Delhi, India




vaccine, immune, epitope, antigen, transcutaneous, pathogenic


Microneedles can be representative for paradigm shift of drug delivery from patient non-compliant parenteral injections to patient compliant drug delivery system, which can be utilized for administration of vaccines particularly along with macromolecular/micromolecular drugs. The concept of microneedles came into existence many decades ago but the use of microneedles to achieve efficient delivery of drugs into the skin became subject of research from mid of 1990’s. Various types of microneedles were utilized to enhance delivery of drugs and vaccines including solid microneedles for pre-treatment of skin to enhance drug permeability, dissolvable polymeric microneedles encapsulating drugs, microneedles coated with drugs and hollow microneedles for infusion of drugs through the skin. Microneedles have shown promising
delivery of vaccines through skin in literature. But the successful utilization of this system for vaccine drug delivery mainly depends on design of device to facilitate microneedle infusion, vaccine stability and storage in system, recovery of skin on removal of microneedle and improved patient compliance. This article reviews the conventional and advanced methods of vaccine drug deliver, microneedles for drug delivery, types of microneedles, advantages of microneedles and potential of microneedles for vaccine drug delivery.


Download data is not yet available.


Metrics Loading ...


Akhtar, N (2014). Microneedles: an innovative approach to transdermal deliverya review. Int J Pharm Pharm Sci, 6(4), 0975–1491.

Alarcon, J.B., Hartley, A.W., Harvey, N.G., Mikszta, J.A (2007). Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clinc Vacc Immunol, 14, 375–381. https://doi.org/10.1128/CVI.00387-06

Apostolopoulos, V., Stojanovska, L (2013). Targeting Antigens to Dendritic Cell Receptors for Vaccine Development. J Drug Del, Article ID 869718. https://doi.org/10.1155/2013/869718

Boks, M.A., Unger, W.W.J., Engels, S., Regina Luttge, R., et. al (2015). Controlled release of a model vaccine by nanoporous ceramic microneedle arrays. Int J Pharm, 491, 375–383. https://doi.org/10.1016/j.ijpharm.2015.06.025

Donnelly, R., Douroumis, D (2015). Microneedles for drug and vaccine delivery and patient monitoring. Drug Deliv. Transl. Res, 5, 311–312. https://doi.org/10.1007/s13346-015-0250-2

Chen, G., Hao, B (2015). Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis. Acta PharmaceuticaSinicaB, 5(6), 569–576. https://doi.org/10.1016/j.apsb.2015.09.006

Chen, M.C., Ling, M.H., Lai, K.Y., Pramudityo, E (2012). Chitosan microneedle patches for sustained transdermal delivery of macromolecules. Biomacromol, 13(12), 4022–4031. https://doi.org/10.1021/bm301293d

Cormier, M., Johnson, B., Ameri, M., Nyam, K (2004). Transdermal delivery of desmopressin using a coated micro needle array patches system. J Control Rel, 97, 503–511. https://doi.org/10.1016/S0168-3659(04)00171-3

Coulman, S., Allender, C., Birchall, J (2006). Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst, 23, 205–258. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v23.i3.20

Courtenay, A.J., Donnelly, R.F (2016). Microneedles: A New Frontier in Nanomedicine Delivery. Pharm Res, 33, 1055–1073. https://doi.org/10.1007/s11095-016-1885-5

Desale, R.S., Wagh, K.S., Akarte, A.M., Baviskar, D.T. et al (2012). Microneedles technology for advanced drug delivery: a review. Int J Pharm Tech Res, 4(1), 181–189. http://www.who.int/influenza_vaccines_plan/resources/deployment/en/

Donnelly, R.F., Morrow, D.I.J., McCarron, P.A., Woolfson, A.D., et. al (2009). Microneedle arrays permit enhanced intradermal delivery of a performed photosensitizer. Photochem Photobiol, 85, 195–204. https://doi.org/10.1111/j.1751-1097.2008.00417.x

Donnelly, R.F., Thakur, R.R.S., Woolfson, A.D (2010). Microneedle based drug delivery system: Microfabrication, drug delivery and safety. Drug Deliv, 17(4), 187–207. https://doi.org/10.3109/10717541003667798

Duan, D., Moeckly, C., Gysbers, J., Novak, C (2013). Enhanced delivery of topically-applied formulations following skin pre treatment with a hand-applied, plastic microneedle array. Curr Drug Del, 8(5), 557–565. https://doi.org/10.2174/156720111796642318

Ghosh, P., Pinninti, R.R., Hammell, D.C., Paudel, K.S (2013). Development of a codrug approach for sustained drug delivery across microneedles-treatment skin. J Pharm Sci, 102(5), 1458–1467. https://doi.org/10.1002/jps.23469

Gill, H.S., Prausnitz, M.R (2007). Coated microneedles for transdermal delivery. J Control Release, 117(2),227–237. https://doi.org/10.1016/j.jconrel.2006.10.017

Gill, H.S., Prausnitz, M.R (2007). Coating formulations for microneedles. Pharm Res, 24, 1369–1380. https://doi.org/10.1007/s11095-007-9286-4

Ita, K (2015). Transdermal Delivery of Drugs with Microneedles–Potential and Challenges. Pharmaceutics, 7, 90–105. https://doi.org/10.3390/pharmaceutics7030090

Ito, Y., Haguiwara, E., Saeki, A., Sugioka, N. et al (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci, 29(1), 82–88. https://doi.org/10.1016/j.ejps.2006.05.011

Jiskoot, W., Bouwstra,J (2012). Microneedle technologies for transdermal drug and vaccine delivery. J Control Rel, 161, 645–655. https://doi.org/10.1016/j.jconrel.2012.01.042

Kocchar, J.S., Zou, S., Chan, S.Y., Kang, L (2012). Protein encapsulation in polymeric microneedles by photolithography. Int J Nanomed, 7, 3143–3154.

Kolli, C.S., Banga, A.K (2008). Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res, 25, 104–113. https://doi.org/10.1007/s11095-007-9350-0

Saroja, C.H., Lakshmi, P.K., Bhaskaran, S (2011). Recent trends in vaccine delivery systems: A review. IntJ PharmInvestig, 1(2), 64–74. https://doi.org/10.4103/2230-973X.82384

Lax, R (2010). Challenges for therapeutic peptides part 2: Delivery Systems. Innov Pharm Tech, 43, 42–46.

Lee, J.W., Sullivan, S.P (2010). Dissolving polymer microneedle patches for influenza vaccination. Nat Med, 16(8), 915–920. https://doi.org/10.1038/nm.2182

Matriano, J.A., Cormier, M., Johnson, J., Young, W.A., Buttery, M., Nyam, K., Daddona, P.E.(2002). Macroflux Microprojection Array Patch Technology:

A New and Efficient Approach for Intracutaneous Immunization. Pharm Res, 19(1), 63–70. https://doi.org/10.1023/A:1013607400040

McAllister, D.V., Allen, M.G., Prausnitz, M.R (2000). Microfabricated microneedles for gene and drug delivery. Ann Rev Biomed Eng, 2, 289–313. https://doi.org/10.1146/annurev.bioeng.2.1.289

Milewski, M., Brogden, N.K., Stinchcomb, A.L (2010) Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.Expert Opin Drug Deliv, 7(5), 617–629. https://doi.org/10.1517/17425241003663228

Mortanto, W., Davis, S.P., Holiday, N.R., Wang, J. et al (2004). Transdermal delivery of insulin using microneedles in vivo. Pharm Res, 21(6), 945–952. https://doi.org/10.1023/B:PHAM.0000029282.44140.2e

Park, J.H., Allen, M.G., Prausnitz, M.R (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res, 23,1008–1019. https://doi.org/10.1007/s11095-006-0028-9

Park, J.H., Allen, M.G (2005). Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Rel, 104(1), 51–66. https://doi.org/10.1016/j.jconrel.2005.02.002

Pawar, R.G., et al (2012). Microneedles: novel approach to transdermal drug delivery system. J Drug Del Ther, 2(1), 76–80. https://doi.org/10.22270/jddt.v2i1.77

Prausnitz, M.R (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56, 581–587. https://doi.org/10.1016/j.addr.2003.10.023

Prausnitz, M.R., Allen, M.G., Henry, S., Mcallister, D.V., et al (2004). Devices and methods for enhanced microneedle penetration of biological barriers. US006743211.

Prausnitz, M.R., john, A., Cormier, M.M., Andrianov, A.K (2009). Microneedles based vaccines. Curr Top Microbiol Immunol, 333, 369–393. https://doi.org/10.1007/978-3-540-92165-3_18

Qiu, Y., Qin, G., Zhang, S., Wu, Y., et al (2012). Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery. Int J Pharm, 437, 51–56. https://doi.org/10.1016/j.ijpharm.2012.07.035

Quinn, H.L., Kearney, M.C., Courtenay, A.J., McCrudden, M.T., Donnelly, R.F (2014). The role of microneedles for drug and vaccine delivery. Expert Opin. Drug Deliv, 11(11), 1–12. https://doi.org/10.1517/17425247.2014.938635

Raphael, A.P., Prow, T.W., Crichton, M.L., Chen, X., Fernando, G.J., Kendall, M.A. (2010). Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small, 6, 1785–1793. https://doi.org/10.1002/smll.201000326

Roxhed. N (2007). A Fully Integrated Microneedle-based Transdermal Drug Delivery System, 064, 1653–5146.

Raphael, A.P., Crichton, M.L., Falconer,R.J., Meliga, S., Chen, X., Fernando, G.J., Huang, H., Kendall, M.A. (2016). Formulations for microprojection/microneedle vaccine delivery: Structure, strength and release profiles. J ControlRel, 225, 40–52. https://doi.org/10.1016/j.jconrel.2016.01.027

Schwendener, R.A (2014). Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines, 2(6), 159–182. https://doi.org/10.1177/2051013614541440

Song, Jae-Min., Kim,Yeu-Chun (2012). DNA Vaccination in the Skin Using Microneedles Improves Protection Against Influenza. Molecular Therapy, 20(7), 1472–1480. https://doi.org/10.1038/mt.2012.69

Srinivas, P., Shanthi, C.L., Sadanandam, M.S (2010). Miconeedles patches in drug delivery: a review. Int J Pharm Tech, 2(3), 329–344.

Stanley, K.A., Smith, K.M (2013). Vaccine delivery with microneedle skin patches in nonhuman primates. Nature biotechnology, 31(12),1082–1085. https://doi.org/10.1038/nbt.2759

Suh, H., Shin,J (2014). Microneedle patches for vaccine delivery. Clin Exp Vaccine Res, 3, 42–49. https://doi.org/10.7774/cevr.2014.3.1.42

Wermeling, D.P., Banks, S.L., Hudson, DA., Gupta, J. et al (2008). Microneedles permit transdermal delivery of a skin impermeant medication to humans. Proc Natl Acad Sci USA, 105(6), 2058–2063. https://doi.org/10.1073/pnas.0710355105

Woolfson, A.D., Donnelly, R.F (2012). Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Rel, 159, 52–59. https://doi.org/10.1016/j.jconrel.2012.01.003

Wu, M.X., Shah. D (2012). Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J ControlRel, 159, 43–51. https://doi.org/10.1016/j.jconrel.2012.01.002

Yuzhakov, V.V (2007). Microneedle array, patch, and applicator for transdermal drug delivery. US20070161964 .

Yuzhakov, V.V (2010). Advanced delivery devices: The AdminPenTM Microneedle device for painless and convenient drug delivery. Drug Deliv Tech, 10(4), 32–36.




How to Cite

Anureet Arora, Manju Nagpal, & Geeta Aggarwal. (2017). Microneedle Mediated Vaccine Delivery: A Comprehensive Review. Journal of Pharmaceutical Technology, Research and Management, 5(2), 163–184. https://doi.org/10.15415/jptrm.2017.52011